Artemis Medicare
Ticker > Company >

Artemis Medicare share price

Artemis Medicare Services Ltd.

NSE: ARTEMISMED BSE: 542919 SECTOR: Hospital & Healthcare Services  56.95 K   67   15

235.50
+8.30 (3.65%)
BSE: 08 Sep 04:01 PM

Price Summary

Today's High

₹ 237.9

Today's Low

₹ 226.3

52 Week High

₹ 348.3

52 Week Low

₹ 208.75

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 3271.85 Cr.

Enterprise Value

₹ 3114.64 Cr.

No. of Shares

13.89 Cr.

P/E

37.2

P/B

4.14

Face Value

₹ 1

Div. Yield

0.19 %

Book Value (TTM)

₹  56.94

CASH

₹ 393.26 Cr.

DEBT

₹ 236.04 Cr.

Promoter Holding

66.53 %

EPS (TTM)

₹  6.33

Sales Growth

8.05%

ROE

14.56 %

ROCE

17.13%

Profit Growth

69.82 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year8.05%
3 Year18.79%
5 Year10.15%

Profit Growth

1 Year69.82%
3 Year36.83%
5 Year32.51%

ROE%

1 Year14.56%
3 Year13.76%
5 Year11.22%

ROCE %

1 Year17.13%
3 Year15.83%
5 Year13.06%

Debt/Equity

0.3067

Price to Cash Flow

23.53

Interest Cover Ratio

4.5842

CFO/PAT (5 Yr. Avg.)

2.18792158461321

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 66.53 0.00
Mar 2025 67.17 44.53
Dec 2024 67.17 44.53
Sep 2024 67.17 44.53
Jun 2024 67.51 44.53
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 36.830685895993% for the Past 3 years.
  • The company has shown a good revenue growth of 18.7926349281393% for the Past 3 years.
  • Company’s PEG ratio is 0.54971585909227.
  • The company has an efficient Cash Conversion Cycle of -113.9344 days.
  • Company has a healthy liquidity position with current ratio of 2.5416.
  • The company has a good cash flow management; CFO/PAT stands at 2.18792158461321.
  • The company has a high promoter holding of 66.53%.

 Limitations

  • The company is trading at a high PE of 37.2.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 216.89 234.67 226.89 234.8 249.8
Total Expenditure 181.22 192.89 190.06 199.26 208.92
Operating Profit 35.68 41.79 36.84 35.54 40.88
Other Income 4.38 7.5 8.8 12.23 6.96
Interest 7.7 7.6 7.65 7.53 7.11
Depreciation 10.22 10.6 10.94 11.25 10.66
Exceptional Items 0 0 0 0 0
Profit Before Tax 22.14 31.08 27.04 29 30.07
Tax 5.22 8.52 6.26 5.79 8.65
Profit After Tax 16.92 22.56 20.78 23.21 21.42
Adjusted EPS (Rs) 1.24 1.64 1.51 1.69 1.54

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 402.06 544.78 714.33 845.23 913.26
Total Expenditure 367.02 478.65 620.55 716.85 763.42
Operating Profit 35.05 66.14 93.78 128.38 149.84
Other Income 3.55 4.92 7.13 7.29 32.92
Interest 12.27 11.17 18.59 29.59 30.48
Depreciation 20.65 21.08 29.47 38.03 43.02
Exceptional Items 3.23 0 0 0 0
Profit Before Tax 8.91 38.81 52.86 68.04 109.25
Tax 1.82 6.23 13.18 18.89 25.8
Net Profit 7.09 32.58 39.69 49.15 83.46
Adjusted EPS (Rs.) 0.54 2.46 2.96 3.62 6.07

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 13.24 13.24 13.41 13.59 13.76
Total Reserves 308.38 348.37 393.01 438.05 828.04
Borrowings 98.77 152.57 198.26 216.49 204.12
Other N/C liabilities 61.42 66.23 104.81 136.01 131.73
Current liabilities 115.68 133.08 197.61 174.27 207.49
Total Liabilities 597.5 713.5 907.09 978.4 1385.14
Assets
Net Block 371.82 476.05 583.75 699.23 729.11
Capital WIP 81.01 62.11 94.68 33.45 38.72
Intangible WIP 0 1.94 0 0 1.68
Investments 4.29 5.59 11.7 15.02 15.02
Loans & Advances 34.43 44.61 57.73 65.98 71.84
Other N/C Assets 0.25 0.57 1.01 0.71 1.43
Current Assets 105.7 122.63 158.23 164.01 527.34
Total Assets 597.5 713.5 907.09 978.4 1385.14
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 8.91 38.81 52.86 68.04 109.25
Adjustment 28.68 36.34 46.44 56.14 44.25
Changes in Assets & Liabilities -8.17 1.85 32.5 -2.24 -0.41
Tax Paid -2.37 -16.33 -2.45 -14.35 -14.01
Operating Cash Flow 27.04 60.67 129.35 107.59 139.08
Investing Cash Flow -34.08 -106.1 -152.53 -89.91 -388.28
Financing Cash Flow 12.73 43.65 29.73 -26.1 276.96
Net Cash Flow 5.69 -1.77 6.55 -8.41 27.76

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 67.51 67.17 67.17 67.17 66.53
constructive finance priv... 67.51 67.17 67.17 67.17 66.53
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 32.49 32.83 32.83 32.83 33.47
artemis medicare services... 1.72 1.71 1.71 1.71 1.69
devlina chakravarty - - 2.57 2.52 3.45
governor of kerala 4.93 4.91 4.91 4.91 4.86
kerala state industrial d... 2.19 2.18 2.18 2.18 2.16
llp - 0.09 0.06 0.05 0.06
devlina chakravarty 2.15 2.57 - - -

Annual Reports

Title Link
Title Link
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit CARE
Credit CARE
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY24
Presentation Q3FY24
Presentation Q3FY23

Company News

Artemis Medicare - Quaterly Results 5 Aug, 5:04 PM Artemis Medicare - Quaterly Results 5 Aug, 5:04 PM Artemis Medicare - Quaterly Results 5 Aug, 5:04 PM Artemis Medicare Services informs about board meeting 30 Jul, 1:02 PM Artemis Medicare Services informs about letter to shareholders 17 Jun, 5:03 PM Artemis Medicare Services informs about outcome of board meeting 11 Jun, 5:22 PM Artemis Medicare - Quaterly Results 12 May, 5:23 PM Artemis Medicare - Quaterly Results 12 May, 5:23 PM Artemis Medicare - Quaterly Results 12 May, 5:23 PM Artemis Medicare Services informs about closure trading window 27 Mar, 5:09 PM Artemis Medicare - Quaterly Results 5 Feb, 1:38 PM Artemis Medicare - Quaterly Results 5 Feb, 1:38 PM Artemis Medicare - Quaterly Results 5 Feb, 1:38 PM Artemis Medicare Services informs about notice of postal ballot 26 Nov, 2:57 PM Artemis Medicare - Quaterly Results 14 Nov, 6:54 PM Artemis Medicare - Quaterly Results 14 Nov, 6:54 PM Artemis Medicare Services informs about analyst meet 20 Aug, 2:53 PM Artemis Medicare Services informs about press release 9 Aug, 6:24 PM Artemis Medicare - Quaterly Results 8 Aug, 3:48 PM Artemis Medicare - Quaterly Results 8 Aug, 3:48 PM Artemis Medicare - Quaterly Results 8 Aug, 3:48 PM Artemis Medicare Services informs about newspaper publication 2 Jul, 4:27 PM Artemis Medicare Services submits AGM notice and annual report 1 Jul, 2:45 PM Artemis Medicare Services informs about newspaper advertisement 28 Jun, 2:16 PM Artemis Medicare Services informs about disclosures 21 May, 5:52 PM Artemis Medicare Services informs about disclosure 21 May, 2:13 PM Artemis Medicare Services raises Rs 330 crore through CCDs 16 May, 3:28 PM Artemis Medicare - Quaterly Results 10 May, 6:36 PM Artemis Medicare - Quaterly Results 10 May, 6:36 PM Artemis Medicare Services informs about newspaper publication 11 Apr, 5:36 PM Artemis Medicare Services signs definitive agreements with IFC 5 Apr, 12:59 PM Artemis Medicare - Quaterly Results 5 Feb, 5:23 PM Artemis Medicare - Quaterly Results 5 Feb, 5:23 PM Artemis Medicare - Quaterly Results 5 Feb, 5:23 PM Artemis Medicare - Quaterly Results 8 Nov, 6:06 PM Artemis Medicare - Quaterly Results 8 Nov, 6:06 PM Artemis Medicare Services gets nod for expansion of Tower III in Gurugram based flagship Hospital 8 Aug, 5:34 PM Artemis Medicare - Quaterly Results 8 Aug, 4:29 PM Artemis Medicare - Quaterly Results 8 Aug, 4:29 PM Artemis Medicare - Quaterly Results 8 Aug, 4:29 PM Artemis Medicare Services opens new centre in Gurugram 24 Jun, 11:09 AM Artemis Medicare Services informs about press release 6 May, 4:07 PM Artemis Medicare Services informs about newspaper advertisement 6 May, 2:34 PM Artemis Medicare - Quaterly Results 5 May, 6:29 PM Artemis Medicare - Quaterly Results 5 May, 6:29 PM Artemis Medicare Services informs about newspaper advertisement 17 Feb, 5:12 PM Artemis Medicare - Quaterly Results 1 Feb, 1:57 PM Artemis Medicare - Quaterly Results 1 Feb, 1:57 PM Artemis Medicare - Quaterly Results 1 Feb, 1:57 PM Artemis Medicare Services informs about allotment under ESOP 20 Dec, 5:02 PM

Artemis Medicare Stock Price Analysis and Quick Research Report. Is Artemis Medicare an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Artemis Medicare. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Artemis Medicare has a PE ratio of 37.1195248700817 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Artemis Medicare has ROA of 7.0621% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Artemis Medicare has a Current ratio of 2.5416.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Artemis Medicare has a ROE of 14.5559%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Artemis Medicare has a Debt to Equity ratio of 0.3067 which means that the company has low proportion of debt in its capital.

  • Sales growth: Artemis Medicare has reported revenue growth of 8.049% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Artemis Medicare for the current financial year is 16.4071553234545%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Artemis Medicare is Rs 0.45 and the yield is 0.1911%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Artemis Medicare is Rs 6.3309. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Artemis Medicare in Ticker for free. Also, one can get the intrinsic value of Artemis Medicare by using Valuation Calculators, which are available with a Finology ONE subscription. 

Artemis Medicare FAQs

Q1. What is Artemis Medicare share price today?
Ans: The current share price of Artemis Medicare is Rs 235.

Q2. What is the market capitalisation of Artemis Medicare?
Ans: Artemis Medicare has a market capitalisation of Rs 3264.907875 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Artemis Medicare?
Ans: The PE ratio of Artemis Medicare is 37.1195248700817 and the P/B ratio of Artemis Medicare is 4.12686872518391, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Artemis Medicare share?
Ans: The 52-week high share price of Artemis Medicare is Rs 350, and the 52-week low share price of Artemis Medicare is Rs 207.71.

Q5. Does Artemis Medicare pay dividends?
Ans: Currently, Artemis Medicare pays dividends. Dividend yield of Artemis Medicare is around 0.1911%.

Q6. What are the face value and book value of Artemis Medicare shares?
Ans: The face value of Artemis Medicare shares is Rs 1, while the book value per share of Artemis Medicare is around Rs 56.9439. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Artemis Medicare?
Ans: Artemis Medicare has a total debt of Rs 236.0432 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Artemis Medicare?
Ans: The ROE of Artemis Medicare is 14.5559% and ROCE of Artemis Medicare is 17.1329%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Artemis Medicare a good buy for the long term?
Ans: The Artemis Medicare long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Artemis Medicare undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Artemis Medicare appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Artemis Medicare’s financials?
Ans: You can review Artemis Medicare’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Artemis Medicare

Artemis Medicare Services Ltd. Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Artemis Medicare Services Ltd. is a leading healthcare company that specializes in providing premium medical services and innovative solutions in the healthcare industry. The company is committed to delivering quality healthcare services that are accessible, affordable, and of the highest standards.

Artemis Medicare Services Ltd. - Share Price

The share price of Artemis Medicare Services Ltd. reflects the market value of the company's stock. Investors and stakeholders closely monitor the share price as it indicates market sentiment and the perceived value of the company. Our website provides you with real-time updates on Artemis Medicare Services Ltd.'s share price, allowing you to track and analyze its performance over time.

Artemis Medicare Services Ltd. - Balance Sheet

Artemis Medicare Services Ltd.'s balance sheet is a financial statement that provides a snapshot of the company's assets, liabilities, and shareholders' equity at a specific point in time. By analyzing the balance sheet, investors can assess the company's financial health, its ability to meet its obligations, and its overall stability. Utilize our pre-built screening tools to gain insights into Artemis Medicare Services Ltd.'s balance sheet, helping you make informed investment decisions.

Artemis Medicare Services Ltd. - Annual Report

The annual report of Artemis Medicare Services Ltd. provides a comprehensive overview of the company's financial performance, business strategies, and future prospects. It includes important information such as the company's revenue, net income, earnings per share, and key developments. At our website, you can access and download Artemis Medicare Services Ltd.'s annual reports, enabling you to delve deeper into the company's operations and evaluate its long-term growth potential.

Artemis Medicare Services Ltd. - Dividend

Dividends are a portion of a company's profits distributed to its shareholders as a return on their investment. Artemis Medicare Services Ltd. regularly evaluates its financial performance and declares dividends, rewarding its shareholders for their participation and confidence in the company. Stay updated on Artemis Medicare Services Ltd.'s dividend payouts through our platform and evaluate the company's dividend history and payout ratio using our pre-built screening tools.

Artemis Medicare Services Ltd. - Quarterly Result

Artemis Medicare Services Ltd. releases quarterly results to provide investors with an interim assessment of its financial performance. These results highlight key financial metrics such as revenue, net income, and earnings per share, allowing investors to gauge the company's progress and make informed decisions. Access Artemis Medicare Services Ltd.'s quarterly results on our website, and utilize our premium features like fair value calculation tools to gain a deeper understanding of the company's financial position.

Artemis Medicare Services Ltd. - Stock Price

The stock price of Artemis Medicare Services Ltd. is determined by supply and demand dynamics in the market. It reflects investors' perception of the company's value and its growth prospects. Our website offers you real-time updates on Artemis Medicare Services Ltd.'s stock price, accompanied by comprehensive charts and analysis. Stay informed about the stock's performance and utilize our pre-built screening tools to identify potential investment opportunities.

Artemis Medicare Services Ltd. - Price Chart

Price charts visually depict the historical movements of a stock's price over a specific period. Analyzing price charts helps investors identify trends, patterns, and potential support and resistance levels. At our website, you can access detailed price charts of Artemis Medicare Services Ltd.'s stock, empowering you to make informed decisions based on technical analysis.

Artemis Medicare Services Ltd. - News

Stay updated with the latest news and events related to Artemis Medicare Services Ltd. Our website provides a comprehensive news section that includes articles, press releases, and other relevant information that impact the company's operations, financial performance, and industry trends. Stay informed on all the key developments with our up-to-date news coverage.

Artemis Medicare Services Ltd. - Concall Transcripts

Artemis Medicare Services Ltd. conducts conference calls, or concalls, to communicate with investors, analysts, and other stakeholders. These concall transcripts provide valuable insights into the company's strategies, financial performance, and future plans. Access Artemis Medicare Services Ltd.'s concall transcripts on our website and dive deeper into the discussions held during these sessions.

Artemis Medicare Services Ltd. - Investor Presentations

Investor presentations offer a comprehensive overview of Artemis Medicare Services Ltd.'s business model, financial performance, growth prospects, and strategic initiatives. Our website allows you to access and download these investor presentations, providing you with valuable information to assess the company's potential as a long-term investment.

Artemis Medicare Services Ltd. - Promoters

The promoters of Artemis Medicare Services Ltd. are individuals or entities that have played a significant role in the formation and growth of the company. Understanding the background, experience, and vision of the promoters provides insights into the company's leadership and its long-term growth strategy. Access information about the promoters of Artemis Medicare Services Ltd. on our website and gain a deeper understanding of the driving forces behind the company's success.

Artemis Medicare Services Ltd. - Shareholders

Artemis Medicare Services Ltd.'s shareholders are individuals or entities that own shares of the company's stock. Understanding the shareholding pattern and the identity of significant shareholders can provide insights into the company's ownership structure and potential influences on decision-making. Our website provides you with detailed information about Artemis Medicare Services Ltd.'s shareholders, helping you assess the company's stability and growth potential.

By providing comprehensive information and analysis on Artemis Medicare Services Ltd., our website equips long-term stock investors with the necessary tools and insights to make informed investment decisions. Access pre-built screening tools, downloadable reports, fair value calculation features, and real-time updates to enhance your stock analysis and maximize your investment potential. 

Artemis Medicare Services Share Capital Development

Over the period from March 2020 to March 2024, Artemis Medicare Services exhibited a gradual increase in share capital from Rs. 13.24 Cr to Rs. 13.59 Cr. The steady growth is reflective of the company’s consistent approach to financing and managing its equity structure.

Artemis Medicare Services Reserves Growth

The total reserves of Artemis Medicare Services showed a robust uplift, climbing from Rs. 300.83 Cr in March 2020 to Rs. 438.05 Cr by March 2024. This significant increase indicates a stronger financial reserve that could support future investments and operational requirements.

Artemis Medicare Services Borrowing Trajectory

Artemis Medicare Services' borrowings have escalated from Rs. 60.57 Cr in March 2020 to Rs. 216.49 Cr in March 2024. The rising debt trend signals that the company may be leveraging to fuel its expansion and asset acquisition strategies.

Artemis Medicare Services Non-Current and Current Liabilities

The company has seen a shifting landscape in its liabilities over the years. Non-current liabilities expanded to Rs. 136.01 Cr and current liabilities adjusted to Rs. 174.27 Cr by March 2024, reflecting a balance in managing long-term and short-term financial obligations.

Artemis Medicare Services Asset Base Enhancement

Artemis Medicare Services has markedly increased its net block from Rs. 387.13 Cr in March 2020 to Rs. 699.23 Cr by March 2024, indicating that the company is enlarging its asset base and possibly its operational capacity.

Artemis Medicare Services Current Assets Status

The current assets showed a rising pattern, growing from Rs. 116.75 Cr to Rs. 164.01 Cr during the same period, suggesting an enhancement in the company's liquidity and operational funding capacity.

This data presents an analysis for the Standalone Balance Sheet of Artemis Medicare Services. The company’s financial health is a crucial factor for investors tracking stock performance on NSE/BSE indices, and essential for those considering market trends, sector analysis, or looking into new IPOs.

Read More
X